Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis

World Journal of Gastroenterology

Volumn 12, Issue 4, 2006, Pages 520-525

  Yamamoto, Takayuki ^a   Umegae, Satoru ^a   Matsumoto, Koichi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Clinical efficacy; Granulocyte and monocyte adsorptive apheresis; Leukocytapheresis; Safety; Ulcerative colitis

Indexed keywords

CELLULOSE ACETATE; CORTICOSTEROID; MESALAZINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADSORPTION; APHERESIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DIZZINESS; DRUG DOSE REDUCTION; EDITORIAL; FEVER; FLUSHING; GRANULOCYTE; HEADACHE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; INTESTINE MUCOSA; JAPAN; LEUKOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NAUSEA; NEUTROPHIL CHEMOTAXIS; QUALITY OF LIFE; RELAPSE; REMISSION; SAFETY; TIME; TREATMENT DURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 33644896218     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i4.520     Document Type: Editorial

References (36)

1. Grisham MB, Kvietys PR. Role of neutrophils in the pathogenesis of inflammatory bowel disease. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd ed. New York: Churchill Livingstone 1997: 73-80
2. Mahida YR. Monocytes and macrophages in inflammatory bowel disease. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd ed. New York: Churchill Livingstone 1997: 81-85
3. Rampton DS. Inflammatory mediators. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd ed. New York: Churchill Livingstone 1997: 107-116
4. Rembacken BJ, Newbould HE, Richards SJ, Misbah SA, Dixon ME, Chalmers DM, Axon AT. Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apher 1998; 2: 93-96
5. Shimoyama T, Sawada K, Tanaka T, Saito Y, Munakata A, Toyota T, Hiwatashi N, Kasukawa R, Ohara M, Asakura H, Honma T, Kimura K, Koiwai H, Saito Y, Suzuki Y, Nagamachi Y, Koitabashi H, Muto T, Nagawa H, Umeda N, Matsueda K, Hayashi N, Iizuka B, Baba S, Nakamura T, Nasu M, Murakami K, Sawada T, Kataoka T. Granulocyte and monocyte apheresis with the G-1 column in the treatment of patients with active ulcerative colitis. Jpn J Apher 1999; 18: 117-131
6. http://www.adacolumn.com/index.htm
7. Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003; 7: 48-59
8. http://www.asahi-kasei.co.jp/medical/en/product/leukocytapheresis /cellsorba.htm
9. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001; 16: 1-9
10. Tomomasa T, Kobayashi A, Kaneko H, Mika S, Maisawa S, Chino Y, Syou H, Yoden A, Fujino J, Tanikawa M, Yamashita T, Kimura S, Kanoh M, Sawada K, Morikawa A. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 2003; 48: 750-754
11. Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003; 1: 28-35
12. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004; 49: 565-571
13. Naganuma M, Funakoshi S, Sakuraba A, Takagi H, Inoue N, Ogata H, Iwao Y, Ishi H, Hibi T. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004; 10: 251-257
14. Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 2004; 70: 36-44
15. Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsumoto K. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 2004; 20: 783-792
16. Domenech E, Hinojosa J, Esteve-Comas M, Gomollon F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 2004; 20: 1347-1352
17. Kanke K, Nakano M, Hiraishi H, Terano A. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liver Dis 2004; 36: 811-817
18. Kim HJ, Kim JS, Han DS, Yang SK, Hahm KB, Lee WI, Kwon SW, Choi JH, Kim WH, Choi KY, Song IS. Granulocyte and monocyte adsorption apheresis in Korean conventional treatment-refractory patients with active ulcerative colitis: a prospective open-label multicenter study. Korean J Gastroenterol 2005; 45: 34-44
19. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-1845
20. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk E, Borgen L. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-1898
21. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-976
22. Noguchi M, Hiwatashi N, Hayakawa T, Toyota T. Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression Ther Apher 1998; 2: 109-114
23. Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, Adachi M, Shimoyama T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47: 1334-1341
24. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol 2002; 97: 2820-2828
25. Takeda Y, Hiraishi K, Takeda H, Shiobara N, Shibusawa H, Saniabadi AR, Adachi M, Kawata S. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood. Inflamm Res 2003; 52: 287-290
26. Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 2003; 7: 334-340
27. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res 2004; 53: 277-283
28. Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Saniabadi A. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 2004; 99: 1532-1538
29. Andoh A, Tsujikawa T, Inatomi O, Deguchi Y, Hata K, Kitoh K, Sasaki M, Mitsuyama K, Fujiyama Y. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis. Ther Apher Dial 2005; 9: 123-127
30. http://www.clinicaltrials.gov/ct/gui/show/NCT00102193
31. Matsui T, Nishimura T, Matake H, Ohta T, Sakurai T, Yao T. Granulocytapheresis for Crohn's disease: a report on seven refractory patients. Am J Gastroenterol 2003; 98: 511-512
32. Cuenca F, Garcia Paredes J, Mendoza JL, Cruz DM, Herrero A, Diaz-Rubio M. Experience with granulocytapheresis in Crohn's disease. Rev Esp Enferm Dig 2004; 96: 501-503, 504-506
33. Kusaka T, Fukunaga K, Ohnishi K, Kosaka T, Tomita T, Yokoyama Y, Sawada K, Fukuda Y, Miwa H, Matsumoto T. Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease. J Clin Apher 2004; 19: 168-173
34. Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Matsumoto T, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol 2004; 39: 1158-1164
35. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974; 1: 1067-1070
36. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996; 334: 841-848